Cargando…
ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219660/ https://www.ncbi.nlm.nih.gov/pubmed/30443287 http://dx.doi.org/10.18632/oncotarget.26230 |
| _version_ | 1783368692978941952 |
|---|---|
| author | Inoue, Daichi Fujino, Takeshi Kitamura, Toshio |
| author_facet | Inoue, Daichi Fujino, Takeshi Kitamura, Toshio |
| author_sort | Inoue, Daichi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6219660 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62196602018-11-15 ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells Inoue, Daichi Fujino, Takeshi Kitamura, Toshio Oncotarget Editorial Impact Journals LLC 2018-10-16 /pmc/articles/PMC6219660/ /pubmed/30443287 http://dx.doi.org/10.18632/oncotarget.26230 Text en Copyright: © 2018 Inoue et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Inoue, Daichi Fujino, Takeshi Kitamura, Toshio ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells |
| title | ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells |
| title_full | ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells |
| title_fullStr | ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells |
| title_full_unstemmed | ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells |
| title_short | ASXL1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells |
| title_sort | asxl1 as a critical regulator of epigenetic marks and therapeutic potential of mutated cells |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219660/ https://www.ncbi.nlm.nih.gov/pubmed/30443287 http://dx.doi.org/10.18632/oncotarget.26230 |
| work_keys_str_mv | AT inouedaichi asxl1asacriticalregulatorofepigeneticmarksandtherapeuticpotentialofmutatedcells AT fujinotakeshi asxl1asacriticalregulatorofepigeneticmarksandtherapeuticpotentialofmutatedcells AT kitamuratoshio asxl1asacriticalregulatorofepigeneticmarksandtherapeuticpotentialofmutatedcells |